Targeting developmental pathways such as SHH in a context-aware manner, accounting for astrocyte-mediated modulation, while accounting for the separate contributions of microenvironmental factors like astrocytes, may improve therapeutic precision against glioblastoma and its stem-like subpopulations. Here, SHH is linked to glioblastoma.